Targeting extrinsic apoptosis in cancer: Challenges and opportunities
1Institute for Experimental Cancer Research in Pediatrics, Goethe-University, Komturstr. 3a, 60528 Frankfurt, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany.
Abstract:
Apoptosis is a form of programmed cell death that plays a critical role in the regulation of various physiological and pathophysiological processes. Since apoptosis is typically disturbed in human cancers, therapeutic targeting of apoptosis represents a promising avenue for the development of novel therapeutic approaches. This strategy is particularly relevant, since many currently used anticancer therapies utilize apoptosis signaling pathways to exert their antitumor activities. A better understanding of these signaling networks and their deregulation in human cancers is anticipated to open new perspectives for the development of apoptosis-targeted therapies for the treatment of cancer.
Insights
Targeting apoptosis, a crucial programmed cell death process, offers a promising strategy for novel cancer therapies. Understanding apoptosis signaling in cancer can lead to more effective cancer treatments.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Apoptosis, or programmed cell death, is vital for normal physiological and pathological processes.
- Dysregulation of apoptosis is a hallmark of human cancers.
- Current cancer therapies often leverage apoptosis signaling pathways for antitumor effects.
Purpose of the Study:
- To highlight the significance of apoptosis in cancer.
- To emphasize the potential of targeting apoptosis for cancer therapy.
- To underscore the need for deeper understanding of apoptosis signaling in cancer.
Main Methods:
- Review of existing literature on apoptosis and cancer.
- Analysis of signaling pathways involved in apoptosis.
- Examination of therapeutic strategies targeting apoptosis.
Main Results:
- Apoptosis plays a critical role in cancer development and progression.
- Targeting apoptosis pathways is a viable strategy for novel anticancer drug development.
- Understanding signaling networks is key to improving apoptosis-based cancer treatments.
Conclusions:
- Therapeutic targeting of apoptosis is a promising approach for cancer treatment.
- Further research into apoptosis signaling in cancer will drive the development of new therapies.
- Apoptosis-targeted therapies hold significant potential for improving patient outcomes.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
12:28Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
Published on: January 11, 2019
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Apoptosis
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
